Multiple sclerosis and related disorders
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Risk of dementia in older veterans with multiple sclerosis..
-.
2023
-
Magnetic resonance fingerprinting in multiple sclerosis..
-.
2023
-
Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis study..
-.
2023
-
A qualitative exploration of the rehabilitation perceptions and experiences of persons with early multiple sclerosis..
-.
2023
-
Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis..
-.
2022
-
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic..
-.
2022
-
Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years..
-.
2022
-
Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study..
-.
2022
-
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis..
-.
2022
-
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis..
-.
2022
-
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)..
-.
2022
-
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis..
-.
2022
-
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age..
-.
2021
-
Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)..
-.
2021
-
The cholesterol autoxidation products, 7-ketocholesterol and 7β-hydroxycholesterol are associated with serum neurofilaments in multiple sclerosis..
-.
2021
-
Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: A cross-sectional study..
-.
2021
-
Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis..
-.
2020
-
Late onset multiple sclerosis is associated with more severe ventricle expansion..
-.
2020
-
Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis..
-.
2020
-
Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory study..
-.
2020
-
Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures..
298-304.
2018
-
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients..
37-42.
2018
Identity
International Standard Serial Number (ISSN)